Le Lézard
Classified in: Covid-19 virus
Subjects: Product/Service, Webcast

Contagion® to Host Live CME Webinar on COVID-19 for Clinicians on Wednesday, March 25th


Contagion®, the nation's leading multimedia resource dedicated to providing up-to-date, disease-specific information to health care practitioners and specialists in infectious diseases, is partnering with Physicians' Education Resource® (PER®) to host a live CME-Certified webinar on "COVID-19 for Clinicians: What You Need to Know" on Wednesday, March 25, at 6 p.m. EDT.

"As a leader in the infectious disease space, it is our responsibility to quickly educate health care professionals on the rapidly evolving COVID-19 outbreak through Contagion, which has been at the forefront of the pandemic since the beginning," said Mike Hennessy Jr., president and CEO of MJH Life Sciencestm, parent company of Contagion®. "To make it even more practical, this webcast will also be certified to provide continuing medical education to our clinicians through the support of PER®, a leading accredited provider of CME."

With over 200,000 confirmed cases in the world, novel coronavirus is a rapidly evolving public health threat. Infectious disease clinicians are looking for accurate information to help in the diagnosis, management, and potential treatment of COVID-19. The webcast will analyze the changing epidemiology of COVID-19, present the latest data on the modes of transmission and review possible treatments in the pipeline. The program is designed for infectious disease clinicians, epidemiologists, infection preventionists, primary care physicians and any health care providers interested in the treatment and management of the new coronavirus.

The featured speakers for this program will be Helen W. Boucher, M.D., FACP, FIDSA, chief, division of geographic medicine and infectious diseases, Tufts Medical Center; Carlos del Rio, M.D., director, clinical sciences and international research, Emory Center for AIDS Research; Stanley Deresinski, M.D., clinical professor of medicine, infectious diseases, Stanford University; and Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, editor-in-chief of Contagion®, clinical professor, Temple University.

"Contagion® is leading the charge in covering the COVID-19 pandemic, and PER® is proud to partner with this leading voice in infectious disease and provide continuing medical education credit for this live webcast, which makes it all the more valuable for clinicians on the front lines of the COVID-19 response," added Phil Talamo, president of PER®.

With certification by the accredited provider Physicians' Education Resource, (PER), this live webinar will provide participants the opportunity to earn 1.0 AMA PRA Category 1 Creditstm and 1.0 nursing contact hour through the Accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing,

The Contagion® coronavirus specialty page provides clinical news and articles, links to condition-specific resources and videos on the coronavirus. Click here to stay up to date on COVID-19.

For more information and to register for the webcast, click here.

About Contagion®
Contagion® is a fully integrated publication that provides health care practitioners and aligned professionals with timely information and resources to improve patient outcomes and positively affect the identification, diagnosis, treatment and prevention of infectious disease. It also incorporates the Outbreak Monitor, which offers real-time information about infectious disease outbreaks by geographical region. Contagion® is a brand of MJH Life Sciencestm, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.

About Physicians' Education Resource® (PER®)
Since 1995, PER® has been dedicated to advancing cancer care through professional education and now advances patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER® initiated continuing medical education (CME) programming in the cardiovascular and endocrinology areas. While expanding into topics outside of oncology, PER® stands as the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is a brand of MJH Life Sciencestm, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.


These press releases may also interest you

at 17:20
Providing a comprehensive overview of NOVAGOLD's Environmental, Social and Governance (ESG) performance, emphasizing remarkable health and safety records, steadfast dedication to environmental protection, continuous community investment, extensive...

at 16:45
Dogness (International) Corporation ("Dogness" or the "Company") , a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced its financial results for the six months ended December...

at 16:25
Inseego Corp. (the "Company"), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises, and SMBs, announced today that as a result of its improving liquidity position and financial results,...

at 16:10
Flux Power Holdings, Inc. , a developer of advanced lithium-ion energy storage solutions for electrification of commercial and industrial equipment, today announced the appointment of Mark Leposky, a senior-level executive and entrepreneur, to its...

at 16:10
PPG today reported financial results for the first quarter 2024. First Quarter Consolidated Results $ in millions, except EPS 1Q 2024 1Q 2023 YOY change Net sales $4,311 $4,380 (2)% Net...

at 16:10
Metropolitan Bank Holding Corp. (the "Company") , the holding company for Metropolitan Commercial Bank (the "Bank"), reported net income of $16.2 million, or $1.46 per diluted common share, for the first quarter of 2024 compared to $14.6 million, or...



News published on and distributed by: